Optimal dosing of vobramitamab duocarmazine, a CD276 (B7-H3) antibody-drug conjugate, leads to durable eradication of Acute Myeloid Leukemia in preclinical xenograft models
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Danielle Kirkey, Melia Blankenfeld, Deryk Loo, Isabel Lira, Grace Hawkins, Nika Panahi, Bruce Liu, Rhonda Ries, Jack H. Peplinski, Ezio Bonvini, Stephen Eck, Soheil Meshinchi
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108443471
Cites:
Cited by:
Related to: